Advertisement
Person › Details
Kemal Malik (Bayer AG)
Malik, Kemal (Bayer 201402– Executive Board Member for Innovation joined Bayer 1995 before BMS UK)
Organisation | Bayer AG | |
Group | Bayer (Group) | |
Former/major organisation | Bristol Myers Squibb (BMS) (Group) | |
Product | pharmaceutical | |
Product 2 | CHEMICALS | |
Record changed: 2019-10-23 |
Advertisement
More documents for Kemal Malik
- [1] CRISPR Therapeutics AG. (10/21/19). "Press Release: CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics". Leverkusen, Zug & Cambridge, MA....
- [2] Bayer AG. (10/10/19). "Press Release: Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-driven Drug discovery and Disease Diagnosis". Leverkusen & Reading....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top